Jan K. Villadsen

Jan K. Villadsen has a diverse work experience in the biotech and finance industries. Jan started their career as the Underdirektør and Head of Debt Capital Markets at Nykredit Markets from December 2009 to April 2016. Jan then worked as the CFO at Gubra from June 2016 to January 2021. Their responsibilities included financial affairs and management reporting.

In 2021, Jan began working as a CFO at Lactobio, a biotech company focusing on microbial solutions. Jan assisted the management team and the board in financial affairs, new financing, management reporting, budgeting, forecasting, projections, and valuation. Jan left their role in June 2022.

Jan also had roles as a Financial Advisor at Inthera Bioscience AG, a biotech startup Octarine, Pephexia Therapeutics ApS, and a CFO at Cerebriu, where they assisted the management team and the board in financial affairs, financing, management reporting, budgeting, and forecasting.

In 2022, Jan became the Head of Finance at Asgard Therapeutics, a biotech company specializing in cancer immunotherapy. Their responsibilities included assisting the management team in all financial affairs, such as management reporting, budgeting, forecasting, financing, valuation, and other related issues.

In 2023, Jan became the CFO at InProTher, a biotech company. Their responsibilities involve assisting in all financial affairs, including financing and reporting. Jan also joined Commit Biologics as a Financial Advisor, where they provide assistance in financial affairs, financing, and reporting.

Overall, Jan K. Villadsen has extensive experience in financial roles within the biotech industry, specializing in management reporting, financing, budgeting, and forecasting.

Jan K. Villadsen obtained a Graduate Diploma in Business Administration, Organisation & Management from Copenhagen Business School, which they pursued from 1999 to 2001. Prior to that, they also completed a Graduate Diploma in Business Administration, with a specialization in International Business, at the same institution from 1990 to 1992. The field of study for both degrees was not specified.